Federal rescheduling stalls this Congress; only study mandates or veteran pilots advance.

Changing how the federal government classifies psychedelics — which would make research and treatment much easier — is not going to happen in this session of Congress. The most that's likely to pass is laws requiring more studies or small pilot programs letting military veterans access psychedelic treatments. The DEA (the US Drug Enforcement Administration) and other agencies are resistant to bigger changes.

Consensus of 3 agents: legislator, dea_officer, fda_reviewer. 1 dissenting.